ACT Plans to Boost Pharmac Funding | Auckland News

ACT’s David Seymour unveils a bold plan to quadruple Pharmac’s funding to 12% of total health spending by 2033—up from just under 5%—without cutting existing services. He argues that smarter medicine investment, like funding Trikafta for cystic fibrosis, can slash long-term costs by preventing expensive procedures. Seymour contends Pharmac has been undervalued despite its efficiency and tough negotiations, and promises the agency will stay rigorous even with new funds. With projections showing Pharmac’s budget could hit $5.4–6.1 billion by 2033, the plan seeks to rebalance healthcare spending to unlock better public health outcomes and future savings. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/488426afd605f034